Unbiased metagenomic exploration of transfusion‐transmitted infections with nanopore sequencing
Transfusion · 2026-11 · 66 (11) · 2273-2283
DOI: 10.1111/trf.70051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 26.12.2025. Verfasst von Viswanath Ragupathy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA. Hauptthemen laut MEDLINE: Nanopore Sequencing, Metagenomics, Transfusion Reaction, Blood-Borne Pathogens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Intramural Research Funding from the US Food and Drug Administration (FDA).
Abstract (Originalsprache)
Background
Despite advances in blood safety, emerging infectious agents continue to pose risks to the blood supply. Traditional nucleic acid testing assays primarily target known pathogens, limiting the detection of novel microbes. Nanopore metagenomic sequencing enables agnostic identification of diverse pathogens, potentially enhancing transfusion safety surveillance. Study Design and Methods We assessed the analytical performance and limit of detection (LoD) of a nanopore MinION metagenomic sequencing workflow for pathogen detection in clinical plasma samples. DNA/RNA was extracted from 14 archived samples from individuals with confirmed infections (HIV, HBV, HCV, WNV), followed by cDNA synthesis, barcoded library preparation, and nanopore sequencing. Quantitative reference panels were tested, and data were analyzed using a comprehensive bioinformatics pipeline.
Results
Metagenomic sequencing generated over 2 million reads, with 2.3% of reads mapping to microbial sequences. Key transfusion‐transmissible viruses, including West Nile virus (WNV), HIV, and hepatitis C virus (HCV), were reliably detected, while protocol modifications enabled HBV identification. Strain‐level characterization identified HIV‐1 subtype B, HCV genotypes 1a, 2b, 4a, HBV genotype C, and WNV lineage 1A. High viral loads produced extensive genome coverage, while lower loads yielded limited recovery. Co‐infections, including human pegivirus (HPgV‐2) and torque teno virus (TTV), were identified. The workflow detected viral targets at 10 3 genome copy equivalents (GCEs)/mL, with > 50% genome coverage achieved at 10 4 GCE/mL.
Discussion
Nanopore metagenomic sequencing enables comprehensive detection of blood‐borne pathogens in plasma samples. This approach offers a promising complementary strategy for enhancing transfusion safety surveillance, and the demonstrated strain‐level characterization supports its potential utility for blood safety applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
- Office of Biostatistics and Pharmocovigilance, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
ORCID-Profile: Kylan Kelley
Förderung
- Intramural Research Funding from the US Food and Drug Administration (FDA)
Zitieren
APA
Ragupathy, V., Kelley, K., Zhao, J., Mazo, I., & Hewlett, I. (2026). Unbiased metagenomic exploration of transfusion‐transmitted infections with nanopore sequencing. Transfusion, 66(11), 2273-2283. https://doi.org/10.1111/trf.70051
Vancouver
Ragupathy V, Kelley K, Zhao J, Mazo I, Hewlett I. Unbiased metagenomic exploration of transfusion‐transmitted infections with nanopore sequencing. Transfusion. 2026;66(11):2273-2283. doi:10.1111/trf.70051
BibTeX
@article{Ragupathy2026,
author = {Ragupathy, Viswanath and Kelley, Kylan and Zhao, Jiangqin and Mazo, Ilya and Hewlett, Indira},
title = {Unbiased metagenomic exploration of transfusion‐transmitted infections with nanopore sequencing},
journal = {Transfusion},
year = {2026},
volume = {66},
number = {11},
pages = {2273--2283},
doi = {10.1111/trf.70051}
}
EUVIMED